Granules India Limited
NSE:GRANULES.NS
584.5 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Granules India Limited |
Symbool | GRANULES.NS |
Munteenheid | INR |
Prijs | 584.5 |
Beurswaarde | 141,664,680,500 |
Dividendpercentage | 0.38% |
52-weken bereik | 360.1 - 721 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. |
Website | https://www.granulesindia.com |
An error occurred while fetching data.
Over Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)